Protocol Number:
AHEP0731
Study Name:
Treatment of Children with All Stages of Hepatoblastoma with Temsirolimus (IND#122782, NSC#683864) Added to High Risk Stratum Treatment
Age Group:
Pediatrics
Background Information:
See full details
Protocol Number:
NCT03582618
Study Name:
A Phase 2, Open-Label Study with Orally Administered CVM-1118 and Sorafenib in Subjects with Advanced Hepatocellular Carcinoma (TaiRx)
Age Group:
Adult
Background Information:
The purpose of this study is to test the effectiveness, safety, and tolerability of an investigational drug combination of CVM-1118 and sorafenib in participants with advanced HCC.
See full details